Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Keros Therapeutics (KROS) Tax Provisions: 2020-2024

Historic Tax Provisions for Keros Therapeutics (KROS) over the last 3 years, with Dec 2024 value amounting to $300,000.

  • Keros Therapeutics' Tax Provisions was N/A to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $300,000 for FY2024, which is N/A change from last year.
  • Per Keros Therapeutics' latest filing, its Tax Provisions stood at $300,000 for FY2024, which was down 85.08% from $2.0 million recorded in FY2021.
  • Over the past 5 years, Keros Therapeutics' Tax Provisions peaked at $2.0 million during FY2021, and registered a low of -$172,000 during FY2020.
  • Over the past 1 years, Keros Therapeutics' median Tax Provisions value was $300,000 (recorded in 2024), while the average stood at $300,000.
  • Data for Keros Therapeutics' Tax Provisions shows a peak YoY skyrocketed of 1,269.19% (in 2021) over the last 5 years.
  • Keros Therapeutics' Tax Provisions (Yearly) stood at -$172,000 in 2020, then soared by 1,269.19% to $2.0 million in 2021, then reached $300,000 in 2024.